NEWS DETAIL

Percubaan COMMODORE: Kajian Susulan Jangka Panjang Gefitinib vs. Kemoterapi Salvage dalam Leukemia Myeloid Akut Mutan FLT3 yang Berulang/Refraktori – aml-hub.com

Percubaan COMMODORE: Kajian Susulan Jangka Panjang Gefitinib vs.

Maklumat Perubatan

Kandungan penuh artikel

During the European Hematology Association (EHA) 2025 Congress, Jianxiang Wang presented the long-term follow-up data from the phase III COMMODORE trial of gilteritinib vs salvage chemotherapy in predominantly Asian patients with R/R FLT3m AML.

Produk Berkaitan Artikel Ini

Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.

Soalan Lazim

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Gefitinib – Beli Dalam Talian Lucius Gilteritinib – Beli Dalam Talian GILLIDX Gilteritinib 40mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat